Detalhe da pesquisa
1.
Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial.
J Int Assoc Provid AIDS Care
; 23: 23259582241245223, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38613372
2.
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care.
HIV AIDS (Auckl)
; 16: 133-140, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38645753
3.
Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART Era.
AIDS Res Hum Retroviruses
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38481376
4.
Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort.
AIDS Res Hum Retroviruses
; 39(12): 636-643, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37489298
5.
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort.
Infect Dis Ther
; 12(12): 2807-2817, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966701
6.
Lipid Changes After Switch From TDF to TAF in the OPERA Cohort: LDL Cholesterol and Triglycerides.
Open Forum Infect Dis
; 9(1): ofab621, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028335
7.
HIV retention in care: results and lessons learned from the Positive Pathways Implementation Trial.
BMC Prim Care
; 23(1): 297, 2022 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36424550
8.
Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness study.
J Int AIDS Soc
; 25(9): e26006, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097674
9.
Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE).
J Int AIDS Soc
; 25(9): e26003, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094142
10.
Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization.
Clin Drug Investig
; 41(11): 955-965, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34546533
11.
Weight gain before and after switch from TDF to TAF in a U.S. cohort study.
J Int AIDS Soc
; 24(4): e25702, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33838004
12.
Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents.
Open Forum Infect Dis
; 8(8): ofab363, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34381843
13.
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study.
Infect Dis Ther
; 9(1): 41-52, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31701370